GSE128076 doxycycline HEK293 2 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE128076_doxycycline_HEK293_2_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE128076_doxycycline_HEK293_2_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE128076_doxycycline_HEK293_2_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE128076_doxycycline_HEK293_2_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

ribosomal protein S18

Gene

small nucleolar RNA host gene 16

Gene

non-coding RNA activated by DNA damage

Gene

BAIAP2 divergent transcript

Gene

MT-CO2 pseudogene 12

Gene

p53 upregulated regulator of p53 levels

Gene

VPS9D1 antisense RNA 1

Gene

MT-ATP6 pseudogene 1

Gene

dual specificity phosphatase 13A

Gene

sorbitol dehydrogenase 2, pseudogene

  • Gene

    ribosomal protein S18


  • Gene

    small nucleolar RNA host gene 16


  • Gene

    non-coding RNA activated by DNA damage


  • Gene

    BAIAP2 divergent transcript


  • Gene

    MT-CO2 pseudogene 12


  • Gene

    p53 upregulated regulator of p53 levels


  • Gene

    VPS9D1 antisense RNA 1


  • Gene

    MT-ATP6 pseudogene 1


  • Gene

    dual specificity phosphatase 13A


  • Gene

    sorbitol dehydrogenase 2, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.